Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 23, 1125-1136, September 1, 1963]
© 1963 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartz, H. S.
Right arrow Articles by Philips, F. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, H. S.
Right arrow Articles by Philips, F. S.

Pharmacology of Mitomycin C

IV. Effects in Vivo on Nucleic Acid Synthesis; Comparison with Actinomycin D*

Herbert S. Schwartz, S. S. Sternberg and F. S. Philips

( Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, New York)

Mitomycin C is selectively toxic to proliferating cells in intact mammals, an effect presumably mediated by an inhibition of deoxyribonucleic acid synthesis. Actinomycin D is similarly cytotoxic but by a different mode of action. Both agents inhibit in vivo the incorporation of labeled thymidine into the DNA of rat small intestine, thymus, and bone marrow. Mitomycin causes prompt inhibition of thymidine incorporation and, simultaneously, of mitosis. These effects are seen in intestine within 1 hour after mitomycin injection, and they precede karyorrhexis and inhibition of RNA synthesis. Intestinal DNA, which has been prelabeled with thymidine-C14, is, however, stable for at least 2 hours after mitomycin treatment, though subsequently there are substantial losses of the label. In contrast to mitomycin's prompt action, the actinomycin effect on thymidine incorporation and on mitosis is characterized by a relatively long period of latency. Moreover, the actinomycin effect occurs together with or is preceded by karyorrhexis. Actinomycin also inhibits the incorporation of formate into RNA and DNA; these inhibitions appear simultaneously.

* Aided by CCNSC Contract No. SA-43-p4-2445 from the National Cancer Institute, U.S.P.H.S.

Received 3/23/63.


This article has been cited by other articles:


Home page
ScienceHome page
H. S. Schwartz, J. E. Sodergren, and F. S. Philips
Mitomycin C: Chemical and Biological Studies on Alkylation
Science, November 29, 1963; 142(3596): 1181 - 1183.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1963 by the American Association for Cancer Research.